NMTC NEUROONE MEDICAL TECHNOLOGIES Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NMTC

Price (delayed)

$1.21

Market cap

$31.38M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.68

Enterprise value

$28.72M

Highlights
The company's debt has shrunk by 86% YoY and by 62% QoQ
NEUROONE MEDICAL TECHNOLOGIES's gross profit has shrunk by 78% YoY and by 62% QoQ
The gross margin has shrunk by 71% YoY and by 53% QoQ
Sector: Healthcare
Industry: Medical Devices
Peers: OBIO OM

Key stats

What are the main financial stats of NMTC
Market
Shares outstanding
25.93M
Market cap
$31.38M
Enterprise value
$28.72M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.56
Price to sales (P/S)
10.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.2
Earnings
Revenue
$2.82M
EBIT
-$13.47M
EBITDA
-$13.14M
Free cash flow
-$13.61M
Per share
EPS
-$0.68
Free cash flow per share
-$0.57
Book value per share
$0.18
Revenue per share
$0.12
TBVPS
$0.24
Balance sheet
Total assets
$5.82M
Total liabilities
$1.4M
Debt
$20,982
Equity
$4.42M
Working capital
$3.71M
Liquidity
Debt to equity
0
Current ratio
3.68
Quick ratio
2.33
Net debt/EBITDA
0.2
Margins
EBITDA margin
-466.6%
Gross margin
26.1%
Net margin
-478.5%
Operating margin
-481.7%
Efficiency
Return on assets
-200.4%
Return on equity
-267.8%
Return on invested capital
-955.9%
Return on capital employed
-303.5%
Return on sales
-478.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NMTC stock price

How has the NEUROONE MEDICAL TECHNOLOGIES stock price performed over time
Intraday
4.31%
1 week
9.01%
1 month
-1.63%
1 year
-17.69%
YTD
-23.42%
QTD
0.83%

Financial performance

How have NEUROONE MEDICAL TECHNOLOGIES's revenue and profit performed over time
Revenue
$2.82M
Gross profit
$735,138
Operating income
-$13.56M
Net income
-$13.47M
Gross margin
26.1%
Net margin
-478.5%
The company's net margin has shrunk by 96% YoY and by 38% QoQ
NMTC's operating margin has plunged by 95% YoY and by 37% from the previous quarter
NEUROONE MEDICAL TECHNOLOGIES's gross profit has shrunk by 78% YoY and by 62% QoQ
The gross margin has shrunk by 71% YoY and by 53% QoQ

Growth

What is NEUROONE MEDICAL TECHNOLOGIES's growth rate over time

Valuation

What is NEUROONE MEDICAL TECHNOLOGIES stock price valuation
P/E
N/A
P/B
6.56
P/S
10.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.2
The EPS has declined by 21% year-on-year and by 4.6% since the previous quarter
NEUROONE MEDICAL TECHNOLOGIES's equity has decreased by 46% YoY and by 29% from the previous quarter
The P/B is 19% above the last 4 quarters average of 5.5
The price to sales (P/S) is 41% higher than the last 4 quarters average of 7.3
NMTC's revenue is down by 23% year-on-year and by 17% since the previous quarter

Efficiency

How efficient is NEUROONE MEDICAL TECHNOLOGIES business performance
NMTC's ROA has plunged by 170% YoY and by 30% from the previous quarter
The ROS has dropped by 96% year-on-year and by 38% since the previous quarter
The company's return on invested capital has shrunk by 69% YoY and by 54% QoQ
The return on equity has declined by 35% since the previous quarter

Dividends

What is NMTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NMTC.

Financial health

How did NEUROONE MEDICAL TECHNOLOGIES financials performed over time
The quick ratio has shrunk by 60% YoY and by 22% QoQ
NMTC's current ratio is down by 45% year-on-year and by 10% since the previous quarter
The company's debt is 100% lower than its equity
NMTC's debt to equity has shrunk by 100% QoQ and by 100% YoY
The company's debt has shrunk by 86% YoY and by 62% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.